Pain Processing: 

How CoQ10 Impacts Pain Processing

Patients often inquire about what supplement brands and products are recommended Accurate Clinic. In an effort to field these questions, four well known supplement brands are presented here for comparison. This is not meant to be an exhaustive review, but rather a simple resource for those looking for guidance only.

 

See:

     How Nutraceuticals Impact Pain Processing

  1. How Acetyl-L-Carnitine (ALC) Impacts Pain Processing
  2. How Alpha-Lipoic Acid (ALA) impacts pain processing
  3. How Boswellia Impacts Pain Processing
  4. How CoQ10 Impacts Pain Processing
  5. How Curcumin Impacts Pain Processing
  6. How Magnesium Impacts Pain Processing
  7. How Melatonin Impacts Pain Processing
  8. How Omega-3 fatty acids (EPA and DHA) Impact Pain Processing
  9. How N-Acetyl Cysteine (NAC) Impacts Pain Processing
  10. How Nicotinamide Riboside (NR) Impacts Pain Processing
  11. How PEA (Palmitoylethanolamide) Impacts Pain Processing
  12. How Quercetin Impacts Pain Processing
  13. How Resveratrol Impacts Pain Processing
  14. How Sulforaphane (SFN): Impacts Pain Processing
  15. How Taurine Impacts Pain Processing

 

 

Key to Links:

  • Grey text – handout
  • Red text – another page on this website
  • Blue text – Journal publication

Definitions and Terms Related to Pain

 

 

See (on this page):

CoQ10: Pain Processing Effects vs. Direct Tissue-Modifying Effects

How CoQ10 Impacts Pain Processing

Coenzyme Q10 (CoQ10) exerts therapeutic effects across all levels of the pain processing pathway through its unique position as an essential electron carrier in the mitochondrial respiratory chain combined with potent antioxidant, anti-inflammatory, and neuroprotective properties. CoQ10 exists in both oxidized (ubiquinone) and reduced (ubiquinol) forms, enabling it to function as both an energy transfer molecule and a lipid-soluble antioxidant in mitochondria and cell membranes throughout the nervous system.[1][2][3]

These mechanisms address 4 pathological processes central to the Pain Processing treatment paradigm:

  1. Systemic Inflammation
  2. Neuroinflammation
  3. Oxidative Stress
  4. Mitochondrial Dysfunction

The Levels of Pain Processing can be organized as follows:

  • Level 1: Peripheral Nociception (Pain Receptor Transduction): Activation and Sensitization
  • Level 2: Primary Afferent Transmission to Spinal Cord
  • Level 3: Spinal Cord Dorsal Horn Processing (First Synapse)
  • Level 4: Ascending Spinal Pathways and Supraspinal Processing
  • Level 5: Thalamic and Cortical Processing and Pain Perception
  • Level 6: Descending Pain Modulation

 

Level 1: Peripheral Nociception (Transduction)

At the peripheral level, CoQ10 modulates nociceptor function through multiple mechanisms:

Reduction of Peripheral Oxidative Stress: CoQ10 reduces lipid peroxidation in peripheral tissues, including dorsal root ganglia (DRG) and sciatic nerve. In diabetic neuropathy models, CoQ10 treatment significantly reduced tissue lipid peroxidation in DRG and sciatic nerve, protecting peripheral sensory neurons from oxidative damage that contributes to nociceptor sensitization.[1]

Inhibition of Peripheral Inflammatory Mediators: CoQ10 reduces the expression of pro-inflammatory cytokines (IL-1β, IL-6, IL-15) and inducible nitric oxide synthase (iNOS) in peripheral tissues. In osteoarthritis models, CoQ10 treatment significantly reduced IL-1β, IL-6, IL-15, iNOS, and nitrotyrosine expression in affected joints, correlating with reduced secondary tactile allodynia.[4]

Nitric Oxide Regulation: CoQ10 possesses considerable antinociceptive activity, possibly via down-regulating the level of nitric oxide (NO). In acetic acid-induced abdominal constriction models, CoQ10 at 25, 50, and 100 mg/kg significantly reduced abdominal constrictions from 27.0 to 17.7, 9.3, and 1.3 respectively (all p<0.01), demonstrating strong dose-dependent antinociceptive activity.[5]

Protection Against Peripheral Nerve Damage: CoQ10’s antioxidant properties protect peripheral nerve fibers from oxidative injury, preventing the neuronal damage that underlies progressive neuropathy and nociceptor dysfunction.[1][3]

Level 2: Primary Afferent Transmission

CoQ10 supports primary afferent nerve function through several mechanisms:

DRG Neuron Protection: CoQ10 reduces oxidative stress markers in DRG neurons, protecting these critical relay stations for nociceptive transmission. In diabetic mice, CoQ10 administration reduced lipid peroxidation in DRG tissues, correlating with prevention of mechanical allodynia and thermal hyperalgesia.[1]

Mitochondrial Support in Sensory Neurons: As an essential component of the electron transport chain, CoQ10 maintains ATP production in metabolically demanding sensory neurons. This bioenergetic support is critical for maintaining normal nerve conduction and preventing the energy failure that contributes to neuropathic pain.[3][6]

Reduction of Proinflammatory Factors in Peripheral Nervous System: CoQ10 administration reduces proinflammatory factors in the peripheral nervous system, decreasing the inflammatory signaling that sensitizes primary afferent neurons.[1]

Level 3: Spinal Cord Dorsal Horn Processing (First Synapse)

The spinal cord represents a critical site of CoQ10 action for pain modulation:

Inhibition of Glutamate Release: CoQ10 inhibits the release of glutamate from cerebrocortical nerve terminals by suppressing voltage-dependent calcium influx through CaV2.2 (N-type) and CaV2.1 (P/Q-type) channels and inhibiting the mitogen-activated protein kinase (MAPK) signaling pathway.[7] This presynaptic inhibition reduces excitatory neurotransmission at the first pain synapse, potentially attenuating central sensitization.

ERK/Synapsin I Pathway Modulation: CoQ10 decreases the phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2) and synaptic vesicle-associated protein synapsin I, a major presynaptic substrate for ERK. The inhibition of glutamate release by CoQ10 was strongly attenuated in mice without synapsin I, confirming this pathway’s importance.[7]

Reduction of Spinal Cord Oxidative Stress: CoQ10 reduces lipid peroxidation in spinal cord tissues. In diabetic neuropathy models, spinal cord tissues demonstrated increased lipid peroxidation that was reduced by CoQ10 treatment, correlating with attenuation of neuropathic pain behaviors.[1]

Spinal Anti-inflammatory Effects: CoQ10 reduces proinflammatory factors in the central nervous system, including the spinal cord. In spinal cord injury models, CoQ10 treatment significantly decreased TNF-α levels while increasing IL-10 expression, shifting the balance toward anti-inflammatory signaling.[8][9]

Reduction of Spinal Apoptosis: CoQ10 reduces apoptotic signaling in the spinal cord by decreasing the Bax/Bcl-2 ratio and caspase-3 levels, protecting spinal cord neurons from cell death that contributes to chronic pain states.[8][10][11]

Level 4: Ascending Spinal Pathways

CoQ10’s reduction of dorsal horn hyperexcitability decreases the magnitude of nociceptive signals transmitted via ascending pathways:

  • Reduced Signal Amplification: By inhibiting glutamate release and reducing oxidative stress and inflammation in the spinal cord, CoQ10 attenuates the aberrant amplification of pain signals that would otherwise be relayed to supraspinal centers via the spinothalamic, spinoreticular, and spinoparabrachial tracts.[1][7]
  • Neuroprotection of Ascending Pathways: CoQ10’s antioxidant and anti-apoptotic effects protect the neurons that comprise ascending pain pathways from oxidative damage and cell death.[3][10]

Level 5: Thalamic and Cortical Processing

CoQ10 exerts direct effects on supraspinal structures involved in pain processing:

Reduction of Brain Activity in Pain States: In a double-blind randomized placebo-controlled trial in fibromyalgia patients, CoQ10 supplementation reduced brain activity on PET scanning compared to pregabalin alone, suggesting direct modulation of cortical pain processing.[12] This reduction in brain activity correlated with decreased pain scores and anxiety.

NF-κB Pathway Inhibition in Brain: CoQ10 attenuates neuroinflammatory responses through inactivation of NF-κB-dependent inflammatory pathways in neurons. CoQ10 blocks the translocation of NF-κB into the nuclear compartment and prevents degradation of the inhibitory subunit IκB, reducing COX-2 expression and PGE2 production.[13][14]

Nrf2/NQO1 Pathway Activation: CoQ10 activates the Nrf2/NQO1 signaling pathway, promoting antioxidant gene expression and protecting brain neurons from oxidative damage.[11][15]

Microglial Inhibition: CoQ10 inhibits microglial activation in the brain, reducing neuroinflammation. The neuroprotective effect of CoQ10 involves microglia inhibitory mechanisms, as demonstrated by synergistic effects with the microglial inhibitor minocycline.[16][17]

Modulation of Intracellular Signaling Pathways: CoQ10 mediates major intracellular signaling pathways including Nrf2/NQO1, NF-κB, PI3K/AKT/mTOR, MAPK, JAK/STAT, and AMPK pathways, all of which have implications for pain processing and neuroinflammation.[15]

Level 6: Descending Pain Modulation

CoQ10 influences descending modulatory pathways through several mechanisms:

Brainstem Effects: CoQ10 has effects on brainstem structures involved in descending pain modulation. In cardiovascular hypertension studies, CoQ10 affects central mechanisms in the brainstem rostral ventrolateral medulla and hypothalamic paraventricular nucleus, structures that overlap with descending pain modulatory circuits.[18]

Enhancement of Antioxidant Defenses in Modulatory Centers: By reducing oxidative stress in brainstem structures including the periaqueductal gray (PAG) and rostral ventromedial medulla (RVM), CoQ10 may support the normal function of descending inhibitory pathways.[3][18]

Reduction of Neuroinflammation in Descending Pathways: CoQ10’s anti-inflammatory effects extend to brain regions involved in descending modulation, potentially enhancing the efficacy of endogenous pain inhibition.[16][19]

Integration with the 4 Pathological Processes

Pathological Process

CoQ10 Mechanism

Pain Pathway Impact

References

Systemic Inflammation

Meta-analyses confirm significant reductions in CRP, IL-6, and TNF-α; optimal dose 300-400 mg/day; reduces IL-1β, IL-15; inhibits COX-2 and PGE2 production

Decreases peripheral sensitization; reduces inflammatory mediator-induced nociceptor activation

[1], [2], [3], [4]

Neuroinflammation

Inhibits NF-κB signaling (blocks nuclear translocation, prevents IκB degradation); inhibits microglial activation; reduces spinal cord TNF-α; increases IL-10; suppresses STAT3/Th17 pathway

Prevents/reverses central sensitization; reduces glial-mediated synaptic facilitation; protects against neuroinflammatory pain amplification

[5], [6], [7], [8]

Oxidative Stress

Essential component of electron transport chain; direct ROS scavenging in reduced (ubiquinol) form; reduces lipid peroxidation in DRG, sciatic nerve, spinal cord, and brain; increases GSH and SOD; activates Nrf2/NQO1 pathway

Protects neurons throughout pain pathway from oxidative damage; reduces oxidative stress-mediated sensitization

[9], [10], [11], [12], [13]

Mitochondrial Dysfunction

Essential electron carrier in Complexes I-III; restores mitochondrial membrane potential; increases ATP production; enhances OXPHOS activity; activates PGC-1α (mitochondrial biogenesis); reduces mitochondrial oxidative stress

Restores neuronal bioenergetics; prevents excitotoxicity; supports nerve function and regeneration; addresses underlying FM pathophysiology

[10], [11], [14], [15], [16], [17]

 

Clinical Evidence Supporting Pain Pathway Effects

  • Diabetic Neuropathy: In a mouse model of type 1 diabetes, CoQ10 produced significant dose-dependent inhibition of mechanical allodynia and thermal hyperalgesia. Low dose and long-term administration of CoQ10 prevented the development of neuropathic pain, supporting its use as a prophylactic and therapeutic agent.[1]
  • Trigeminal Neuralgia: In a randomized controlled trial, CoQ10 supplementation in carbamazepine-treated trigeminal neuralgia patients reduced pain scores and oxidative stress while increasing antioxidant levels compared to placebo. Increased oxidative stress was identified as potentially involved in TN pathogenesis, and CoQ10 addressed this mechanism.[24]
  • Fibromyalgia: Multiple studies support CoQ10’s efficacy in fibromyalgia:
    1. A randomized, double-blind, placebo-controlled trial (n=20) found that 40 days of CoQ10 supplementation (300 mg/day) produced significant reductions in FIQ scores (p<0.001), with prominent reductions in pain (p<0.001), fatigue, and morning tiredness (p<0.01).[26]
    2. A double-blind randomized placebo-controlled crossover trial in pregabalin-treated FM patients found that CoQ10 supplementation reduced pain, anxiety, and brain activity while decreasing mitochondrial oxidative stress and inflammation and increasing glutathione and SOD levels.[12]
    3. An open-label crossover study (n=22) found CoQ10 (200 mg twice daily) improved pain-related outcomes by 24-37%, fatigue by ~22%, and sleep disturbance by ~33%.[27]
  • Migraine: Meta-analyses support CoQ10’s efficacy in migraine prophylaxis:
    1. A 2021 meta-analysis of 6 RCTs (371 participants) found CoQ10 reduced the duration of headache attacks (MD: -0.19; 95% CI: -0.27 to -0.11; p<0.00001) and reduced the frequency of migraine headache (MD: -1.52; 95% CI: -2.40 to -0.65; p<0.001).[28]
    2. A 2020 meta-analysis of 4 RCTs (221 participants) found CoQ10 significantly reduced migraine attack frequency by 1.87 attacks/month (p<0.001).[29]
    3. The landmark RCT by Sándor et al. found CoQ10 (3 × 100 mg/day) was superior to placebo for attack frequency, headache days, and days with nausea, with a 50% responder rate of 47.6% for CoQ10 versus 14.4% for placebo (NNT: 3).[30]
  • Osteoarthritis: In a rat model of osteoarthritis, CoQ10 demonstrated antinociceptive effects with increased pain withdrawal latency and threshold, while reducing cartilage degeneration and inflammatory mediators (MMP-13, IL-1β, IL-6, IL-15, iNOS).[4]

 

Comparison with Magnesium, ALA, and PEA: Complementary Mechanisms

Feature

Alpha-Lipoic Acid

Magnesium

PEA

CoQ10

References

Primary spinal mechanism

KCC2 restoration; Fos normalization; Nrf2 activation

NMDA receptor voltage-dependent blockade; pNR1 prevention

Glial/microglial phenotype modulation; IL-10 upregulation; glutamate release inhibition

Glutamate release inhibition via CaV2.1/2.2 and ERK/synapsin I; oxidative stress reduction

[1], [2], [3], [4]

Ion channel effects

CaV3.2 T-type inhibition; TRPV1 downregulation via NF-κB

NMDA receptor block; CaV block; NaV modulation; K⁺ channel modulation

TRPV1 desensitization; CaV2.1 inhibition; K⁺ channel opening

CaV2.1 (P/Q-type) and CaV2.2 (N-type) inhibition

[5], [6], [7], [8]

Unique mechanism

LA/DHLA redox couple; glutathione regeneration; metal chelation

Physiological NMDA antagonist; Mg²⁺-ATP cofactor for 300+ enzymes

Entourage effect (↑AEA, ↑2-AG); PPAR-α agonism; mast cell stabilization

Essential ETC component; ubiquinone/ubiquinol redox cycling; AMPK activation

[9], [10], [11], [12]

Antioxidant mechanism

Direct scavenging + Nrf2 activation + glutathione regeneration

Indirect via mitochondrial support; GSH enhancement

Akt/ERK1/2 activation; SOD induction; indirect via inflammation reduction

Direct lipid-soluble antioxidant; Nrf2/NQO1 activation; increases GSH and SOD

[13], [14], [15], [16]

Anti-inflammatory mechanism

NF-κB inhibition; NLRP3 suppression

NF-κB inhibition in microglia; cytokine reduction

PPAR-α→NF-κB inhibition; mast cell stabilization; M1→M2 microglial shift

NF-κB inhibition; microglial

References

  1. Prophylactic and Antinociceptive Effects of Coenzyme Q10 on Diabetic Neuropathic Pain in a Mouse Model of Type 1 Diabetes. Zhang YP, Eber A, Yuan Y, et al. Anesthesiology. 2013;118(4):945-54. doi:10.1097/ALN.0b013e3182829b7b.
  2. Targeted Treatment of Age-Related Fibromyalgia With Supplemental Coenzyme Q10. Hargreaves IP, Mantle D. Advances in Experimental Medicine and Biology. 2021;1286:77-85. doi:10.1007/978-3-030-55035-6_5.
  3. Neuroprotective Effects of Coenzyme Q10 on Neurological Diseases: A Review Article. Bagheri S, Haddadi R, Saki S, et al. Frontiers in Neuroscience. 2023;17:1188839. doi:10.3389/fnins.2023.1188839.
  4. Coenzyme Q10 Ameliorates Pain and Cartilage Degradation in a Rat Model of Osteoarthritis by Regulating Nitric Oxide and Inflammatory Cytokines. Lee J, Hong YS, Jeong JH, et al. PloS One. 2013;8(7):e69362. doi:10.1371/journal.pone.0069362.
  5. Evaluation of Anti-Angiogenic, Anti-Inflammatory and Antinociceptive Activity of Coenzyme Q(10) in Experimental Animals. Jung HJ, Park EH, Lim CJ. The Journal of Pharmacy and Pharmacology. 2009;61(10):1391-5. doi:10.1211/jpp/61.10.0017.
  6. Coenzyme Q10 a Mitochondrial Restorer for Various Brain Disorders. Pradhan N, Singh C, Singh A. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2021;394(11):2197-2222. doi:10.1007/s00210-021-02161-8.
  7. Coenzyme Q10 Inhibits the Release of Glutamate in Rat Cerebrocortical Nerve Terminals by Suppression of Voltage-Dependent Calcium Influx and Mitogen-Activated Protein Kinase Signaling Pathway. Chang Y, Huang SK, Wang SJ. Journal of Agricultural and Food Chemistry. 2012;60(48):11909-18. doi:10.1021/jf302875k.
  8. Coenzyme Q10 Influences on the Levels of TNF-α and IL-10 and the Ratio of Bax/Bcl2 in a Menopausal Rat Model Following Lumbar Spinal Cord Injury. Hassanzadeh S, Jameie SB, Soleimani M, et al. Journal of Molecular Neuroscience : MN. 2018;65(2):255-264. doi:10.1007/s12031-018-1090-6.
  9. Hyperbaric Oxygen Therapy and Coenzyme Q10 Synergistically Attenuates Damage Progression in Spinal Cord Injury in a Rat Model. Ghaemi A, Ghiasvand M, Omraninava M, et al. Journal of Chemical Neuroanatomy. 2023;132:102322. doi:10.1016/j.jchemneu.2023.102322.
  10. Neuroprotective Effects of Coenzyme Q10 and Ozone Therapy on Experimental Traumatic Spinal Cord Injuries in Rats. Gel G, Unluer C, Yılmaz ER, et al. World Neurosurgery. 2024;188:e25-e33. doi:10.1016/j.wneu.2024.04.141.
  11. Coenzyme Q10 Regulation of Apoptosis and Oxidative Stress in H2O2 Induced BMSC Death by Modulating the NRF-2/Nqo-1 Signaling Pathway and Its Application in a Model of Spinal Cord Injury. Li X, Zhan J, Hou Y, et al. Oxidative Medicine and Cellular Longevity. 2019;2019:6493081. doi:10.1155/2019/6493081.
  12. Coenzyme Q10 Supplementation Alleviates Pain in Pregabalin-Treated Fibromyalgia Patients Reducing Brain Activity and Mitochondrial Dysfunction. Sawaddiruk P, Apaijai N, Paiboonworachat S, et al. Free Radical Research. 2019;53(8):901-909. doi:10.1080/10715762.2019.1645955.
  13. Coenzyme Q10 Attenuated Β-Amyloid-Induced Inflammatory Responses in PC12 Cells Through Regulation of the NF-κB Signaling Pathway. Li L, Xu D, Lin J, et al. Brain Research Bulletin. 2017;131:192-198. doi:10.1016/j.brainresbull.2017.04.014.
  14. Coenzyme Q10 Alleviates Neurological Deficits in a Mouse Model of Intracerebral Hemorrhage by Reducing Inflammation and Apoptosis. Yang X, Zhao Y, Yu S, Chi L, Cai Y. Experimental Biology and Medicine (Maywood, N.J.). 2025;250:10321. doi:10.3389/ebm.2025.10321.
  15. Coenzyme Q10 and Intracellular Signalling Pathways: Clinical Relevance. Mantle D. International Journal of Molecular Sciences. 2025;26(22):11024. doi:10.3390/ijms262211024.
  16. Microglial Inhibitory Mechanism of Coenzyme Q10 Against Aβ (1-42) Induced Cognitive Dysfunctions: Possible Behavioral, Biochemical, Cellular, and Histopathological Alterations. Singh A, Kumar A. Frontiers in Pharmacology. 2015;6:268. doi:10.3389/fphar.2015.00268.
  17. Neuroprotective Mechanism of Coenzyme Q10 (CoQ10) Against PTZ Induced Kindling and Associated Cognitive Dysfunction: Possible Role of Microglia Inhibition. Bhardwaj M, Kumar A. Pharmacological Reports : PR. 2016;68(6):1301-1311. doi:10.1016/j.pharep.2016.07.005.
  18. Coenzyme Q10 Effects in Neurological Diseases. Rauchová H. Physiological Research. 2021;70(Suppl4):S683-S714. doi:10.33549/physiolres.934712.
  19. Coenzyme Q10 Attenuates Age-Associated Neurodegeneration via Modulation of Autophagy and Neuroinflammation in Aged Rats. Srivastava P, Verma AK, Yadawa AK, Rizvi SI. Metabolic Brain Disease. 2025;40(8):305. doi:10.1007/s11011-025-01721-8.
  20. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials. Hou S, Tian Z, Zhao D, et al. Molecular Nutrition & Food Research. 2023;67(13):e2200800. doi:10.1002/mnfr.202200800.
  21. Effects of Coenzyme Q10 on Markers of Inflammation: A Systematic Review and Meta-Analysis. Zhai J, Bo Y, Lu Y, Liu C, Zhang L. PloS One. 2017;12(1):e0170172. doi:10.1371/journal.pone.0170172.
  22. Can Coenzyme Q10 Supplementation Effectively Reduce Human Tumor Necrosis Factor-Α and Interleukin-6 Levels in Chronic Inflammatory Diseases? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Farsi F, Heshmati J, Keshtkar A, et al. Pharmacological Research. 2019;148:104290. doi:10.1016/j.phrs.2019.104290.
  23. Effects of Coenzyme Q10 Supplementation on Inflammatory Markers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Fan L, Feng Y, Chen GC, et al. Pharmacological Research. 2017;119:128-136. doi:10.1016/j.phrs.2017.01.032.
  24. Effect of Coenzyme Q10 on Mitochondrial Respiratory Proteins in Trigeminal Neuralgia. Khuankaew C, Apaijai N, Sawaddiruk P, et al. Free Radical Research. 2018;52(4):415-425. doi:10.1080/10715762.2018.1438608.
  25. Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain. Manzar H, Abdulhussein D, Yap TE, Cordeiro MF. International Journal of Molecular Sciences. 2020;21(23):E9299. doi:10.3390/ijms21239299.
  26. Can Coenzyme Q10 Improve Clinical and Molecular Parameters in Fibromyalgia?. Cordero MD, Alcocer-Gómez E, de Miguel M, et al. Antioxidants & Redox Signaling. 2013;19(12):1356-61. doi:10.1089/ars.2013.5260.
  27. Role for a Water-Soluble Form of CoQ10 in Female Subjects Affected by Fibromyalgia. A Preliminary Study. Di Pierro F, Rossi A, Consensi A, Giacomelli C, Bazzichi L. Clinical and Experimental Rheumatology. 2017 May-Jun;35 Suppl 105(3):20-27.
  28. Coenzyme Q10 Supplementation for Prophylaxis in Adult Patients With Migraine-a Meta-Analysis. Sazali S, Badrin S, Norhayati MN, Idris NS. BMJ Open. 2021;11(1):e039358. doi:10.1136/bmjopen-2020-039358.
  29. Effect of Coenzyme Q10 Supplementation on Clinical Features of Migraine: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Parohan M, Sarraf P, Javanbakht MH, Ranji-Burachaloo S, Djalali M. Nutritional Neuroscience. 2020;23(11):868-875. doi:10.1080/1028415X.2019.1572940.
  30. Efficacy of Coenzyme Q10 in Migraine Prophylaxis: A Randomized Controlled Trial. Sándor PS, Di Clemente L, Coppola G, et al. Neurology. 2005;64(4):713-5. doi:10.1212/01.WNL.0000151975.03598.ED.

 

CoQ10: Pain Processing Effects vs. Direct Tissue-Modifying Effects

CoQ10 helps with pain  on how pain is processed by the nervous system and it’s impact on the pathological processes that magnify pain processing. But it also helps with pain due to direct affects modifying tissues, particularly in the case of arthritis. These two faceets are well balanced with curcumin..

Pain Processing Effects:

CoQ10 exerts analgesic effects primarily through antioxidant and mitochondrial mechanisms. In type 1 diabetic neuropathic pain models, CoQ10 produced dose-dependent inhibition of mechanical allodynia and thermal hyperalgesia, reduced lipid peroxidation in dorsal root ganglia, sciatic nerve, and spinal cord, and decreased pro-inflammatory factors in both peripheral and central nervous systems—without affecting blood glucose levels.[20] Long-term low-dose CoQ10 administration prevented the development of neuropathic pain prophylactically.[20]

In type 2 diabetic models, CoQ10 decreased pain hypersensitivity by reducing NF-κB activation (p65 positive neurons) and MAPK expression in dorsal root ganglia, and decreasing CCL2, CXCL10, and TLR4 mRNA in the spinal cord.[21] CoQ10 modulates multiple intracellular signaling pathways relevant to pain processing, including Nrf2/NQO1, NF-κB, PI3K/AKT/mTOR, MAPK, and JAK/STAT pathways.[22]

In trigeminal neuralgia patients, CoQ10 supplementation (added to carbamazepine) reduced pain scores and oxidative stress while increasing antioxidant levels, though it did not affect mitochondrial OXPHOS proteins or cytokine profiles.[23] In fibromyalgia patients on pregabalin, CoQ10 supplementation provided additional pain reduction beyond pregabalin alone, decreased brain activity on PET scan, reduced mitochondrial oxidative stress and inflammation, and increased glutathione and SOD levels.[24]

Direct Tissue-Modifying Effects:

CoQ10 demonstrates significant chondroprotective effects in preclinical OA models. Oral CoQ10 attenuated cartilage degeneration by reducing MMP-13, IL-1β, IL-6, IL-15, iNOS, nitrotyrosine, and RAGE expression in osteoarthritic joints, while increasing pain withdrawal latency and threshold.[25] CoQ10-micelles reduced inflammatory cell death markers (RIP1, RIP3, pMLKL) in synovial tissues and decreased catabolic markers in cultured OA chondrocytes.[26]

In IL-1β-stimulated rat chondrocytes, CoQ10 suppressed MMP-3, MMP-9, and MMP-13 production through MAPK pathway inhibition.[27] In rheumatoid arthritis models, CoQ10 suppressed Th17 cell differentiation, enhanced Treg cells, reduced RANKL-induced osteoclastogenesis, and decreased inflammatory mediators and oxidant factors.[28]

Clinical evidence in arthritis is emerging. A double-blind RCT in 54 RA patients found CoQ10 100mg/day for 2 months significantly improved DAS-28, pain scores, and tender/swollen joint counts compared to placebo, while attenuating serum MMP-3 levels.[29] Another RCT in 44 RA patients found CoQ10 significantly decreased serum MDA (oxidative stress marker) and suppressed TNF-α overexpression.[30] Observational data show OA patients have low CoQ10 status (<0.5 μM), and CoQ10 levels positively correlate with muscle mass, strength, and endurance.[31]

Summary

CoQ10 demonstrates a consistent preclinical-to-clinical translation, particularly for inflammatory arthritis. Its unique mitochondrial-targeted mechanism addresses the bioenergetic dysfunction increasingly recognized in OA and RA pathogenesis. CoQ10 shows prophylactic efficacy in preventing diabetic neuropathic pain development—an effect independent of glycemic control—suggesting direct neuroprotective actions. Clinical RCTs in RA demonstrate meaningful improvements in disease activity (DAS-28), pain, and inflammatory markers (MMP-3, TNF-α). The finding that CoQ10 enhances pregabalin efficacy in fibromyalgia while reducing brain activity on PET imaging suggests central pain-processing effects beyond peripheral antioxidant actions. OA patients consistently show low CoQ10 status, providing a rationale for supplementation.[32][20][29][30][24][31]

References

  1. Deciphering Resveratrol’s Role in Modulating Pathological Pain: From Molecular Mechanisms to Clinical Relevance. Wang B, Jiang HM, Qi LM, et al. Phytotherapy Research : PTR. 2024;38(1):59-73. doi:10.1002/ptr.8021.
  2. Resveratrol-Induced Antinociception Is Involved in Calcium Channels and Calcium/Caffeine-Sensitive Pools. Pan X, Chen J, Wang W, et al. Oncotarget. 2017;8(6):9399-9409. doi:10.18632/oncotarget.14090.
  3. Resveratrol Suppresses Neuroinflammation to Alleviate Mechanical Allodynia by Inhibiting Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling Pathway in a Rat Model of Spinal Cord Injury. Han J, Hua Z, Yang WJ, et al. Frontiers in Molecular Neuroscience. 2023;16:1116679. doi:10.3389/fnmol.2023.1116679.
  4. Evidence for the Analgesic Activity of Resveratrol in Acute Models of Nociception in Mice. Bazzo KO, Souto AA, Lopes TG, et al. Journal of Natural Products. 2013;76(1):13-21. doi:10.1021/np300529x.
  5. Anti-Nociceptive Effect of Resveratrol During Inflammatory Hyperalgesia via Differential Regulation of Pro-Inflammatory Mediators. Singh AK, Vinayak M. Phytotherapy Research : PTR. 2016;30(7):1164-71. doi:10.1002/ptr.5624.
  6. Effects of Resveratrol on Biochemical and Structural Outcomes in Osteoarthritis: A Systematic Review and Meta-Analysis of Preclinical Studies. Zhao W, Zhu Y, Wong SK, et al. Heliyon. 2024;10(13):e34064. doi:10.1016/j.heliyon.2024.e34064.
  7. Resveratrol Downregulates Inflammatory Pathway Activated by Lymphotoxin Α (TNF-β) in Articular Chondrocytes: Comparison With TNF-α. Buhrmann C, Popper B, Aggarwal BB, Shakibaei M. PloS One. 2017;12(11):e0186993. doi:10.1371/journal.pone.0186993.
  8. Protective Effect of Resveratrol Against IL-1β-induced Inflammatory Response on Human Osteoarthritic Chondrocytes Partly via the TLR4/MyD88/NF-κB Signaling Pathway: An “In Vitro Study”. Liu L, Gu H, Liu H, et al. International Journal of Molecular Sciences. 2014;15(4):6925-40. doi:10.3390/ijms15046925.
  9. Primary Osteoarthritis Early Joint Degeneration Induced by Endoplasmic Reticulum Stress Is Mitigated by Resveratrol. Hecht JT, Veerisetty AC, Wu J, et al. The American Journal of Pathology. 2021;191(9):1624-1637. doi:10.1016/j.ajpath.2021.05.016.
  10. Biological Effects of the Plant-Derived Polyphenol Resveratrol in Human Articular Cartilage and Chondrosarcoma Cells. Im HJ, Li X, Chen D, et al. Journal of Cellular Physiology. 2012;227(10):3488-97. doi:10.1002/jcp.24049.
  11. Oral Resveratrol in Adults With Knee Osteoarthritis: A Randomized Placebo-Controlled Trial (ARTHROL). Nguyen C, Coudeyre E, Boutron I, et al. PLoS Medicine. 2024;21(8):e1004440. doi:10.1371/journal.pmed.1004440.
  12. Effect of Resveratrol on Serum Levels of Type II Collagen and Aggrecan in Patients With Knee Osteoarthritis: A Pilot Clinical Study. Marouf BH. BioMed Research International. 2021;2021:3668568. doi:10.1155/2021/3668568.
  13. Magnesium and Pain. Shin HJ, Na HS, Do SH. Nutrients. 2020;12(8):E2184. doi:10.3390/nu12082184.
  14. Magnesium in Pain Research: State of the Art. Srebro D, Vuckovic S, Milovanovic A, et al. Current Medicinal Chemistry. 2017;24(4):424-434. doi:10.2174/0929867323666161213101744.
  15. Oral Application of Magnesium-L-Threonate Alleviates Radicular Pain by Inhibiting Neuro-Inflammation Dependent Central Sensitization of Rats. Li S, Yi H, Yuan F, et al. Brain Research. 2024;1839:148910. doi:10.1016/j.brainres.2024.148910.
  16. Local Magnesium Sulfate Administration Ameliorates Nociception, Peripheral Inflammation, and Spinal Sensitization in a Rat Model of Incisional Pain. Wen ZH, Wu ZS, Huang SY, et al. Neuroscience. 2024;547:98-107. doi:10.1016/j.neuroscience.2024.03.033.
  17. Magnesium Attenuates Chronic Hypersensitivity and Spinal Cord NMDA Receptor Phosphorylation in a Rat Model of Diabetic Neuropathic Pain. Rondón LJ, Privat AM, Daulhac L, et al. The Journal of Physiology. 2010;588(Pt 21):4205-15. doi:10.1113/jphysiol.2010.197004.
  18. Short-Term Magnesium Therapy Alleviates Moderate Stress in Patients With Fibromyalgia: A Randomized Double-Blind Clinical Trial. Macian N, Dualé C, Voute M, et al. Nutrients. 2022;14(10):2088. doi:10.3390/nu14102088.
  19. A Double-Blinded Randomised Controlled Study of the Value of Sequential Intravenous and Oral Magnesium Therapy in Patients With Chronic Low Back Pain With a Neuropathic Component. Yousef AA, Al-deeb AE. Anaesthesia. 2013;68(3):260-6. doi:10.1111/anae.12107.
  20. Prophylactic and Antinociceptive Effects of Coenzyme Q10 on Diabetic Neuropathic Pain in a Mouse Model of Type 1 Diabetes. Zhang YP, Eber A, Yuan Y, et al. Anesthesiology. 2013;118(4):945-54. doi:10.1097/ALN.0b013e3182829b7b.
  21. Diabetic Neuropathic Pain Development in Type 2 Diabetic Mouse Model and the Prophylactic and Therapeutic Effects of Coenzyme Q10. Zhang YP, Song CY, Yuan Y, et al. Neurobiology of Disease. 2013;58:169-78. doi:10.1016/j.nbd.2013.05.003.
  22. Coenzyme Q10 and Intracellular Signalling Pathways: Clinical Relevance. Mantle D. International Journal of Molecular Sciences. 2025;26(22):11024. doi:10.3390/ijms262211024.
  23. Effect of Coenzyme Q10 on Mitochondrial Respiratory Proteins in Trigeminal Neuralgia. Khuankaew C, Apaijai N, Sawaddiruk P, et al. Free Radical Research. 2018;52(4):415-425. doi:10.1080/10715762.2018.1438608.
  24. Coenzyme Q10 Supplementation Alleviates Pain in Pregabalin-Treated Fibromyalgia Patients Reducing Brain Activity and Mitochondrial Dysfunction. Sawaddiruk P, Apaijai N, Paiboonworachat S, et al. Free Radical Research. 2019;53(8):901-909. doi:10.1080/10715762.2019.1645955.
  25. Coenzyme Q10 Ameliorates Pain and Cartilage Degradation in a Rat Model of Osteoarthritis by Regulating Nitric Oxide and Inflammatory Cytokines. Lee J, Hong YS, Jeong JH, et al. PloS One. 2013;8(7):e69362. doi:10.1371/journal.pone.0069362.
  26. Coenzyme Q10 Encapsulated in Micelles Ameliorates Osteoarthritis by Inhibiting Inflammatory Cell Death. Na HS, Woo JS, Kim JH, et al. PloS One. 2022;17(6):e0270351. doi:10.1371/journal.pone.0270351.
  27. Coenzyme Q10 Prevents the Interleukin-1 Beta Induced Inflammatory Response via Inhibition of MAPK Signaling Pathways in Rat Articular Chondrocytes. Li X, Guo Y, Huang S, et al. Drug Development Research. 2017;78(8):403-410. doi:10.1002/ddr.21412.
  28. Coenzyme Q10 Suppresses Th17 Cells and Osteoclast Differentiation and Ameliorates Experimental Autoimmune Arthritis Mice. Jhun J, Lee SH, Byun JK, et al. Immunology Letters. 2015;166(2):92-102. doi:10.1016/j.imlet.2015.05.012.
  29. Effects of Coenzyme Q10 Supplementation on Matrix Metalloproteinases and DAS-28 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nachvak SM, Alipour B, Mahdavi AM, et al. Clinical Rheumatology. 2019;38(12):3367-3374. doi:10.1007/s10067-019-04723-x.
  30. Effects of Coenzyme Q10 Supplementation on Inflammatory Cytokines (TNF-α, IL-6) and Oxidative Stress in Rheumatoid Arthritis Patients: A Randomized Controlled Trial. Abdollahzad H, Aghdashi MA, Asghari Jafarabadi M, Alipour B. Archives of Medical Research. 2015;46(7):527-33. doi:10.1016/j.arcmed.2015.08.006.
  31. Associations Between Coenzyme Q10 Status, Oxidative Stress, and Muscle Strength and Endurance in Patients With Osteoarthritis. Chang PS, Yen CH, Huang YY, Chiu CJ, Lin PT. Antioxidants (Basel, Switzerland). 2020;9(12):E1275. doi:10.3390/antiox9121275.
  32. Mitochondrial Quality Control in Cartilage Damage and Osteoarthritis: New Insights and Potential Therapeutic Targets. Liu D, Cai ZJ, Yang YT, et al. Osteoarthritis and Cartilage. 2022;30(3):395-405. doi:10.1016/j.joca.2021.10.009.

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.

 

 

.